RebrAIn’s news

Focused Ultrasound Foundation Highlights RebrAIn’s AI Innovations in Neurosurgery

We are excited to share that the Focused Ultrasound Foundation has featured RebrAIn for our pioneering use of artificial intelligence in brain targeting.

The article details how our supervised AI-driven platform, Optim MRI, enhances precision and effectiveness in neurosurgical procedures such as Deep Brain Stimulation (DBS). This innovative technology, developed by Professor Emmanuel Cuny and Dr. Nejib Zemzemi, aims to improve patient outcomes and expand treatment options.

Discover our groundbreaking work by reading the full article.

Back to Resources

Our latest public updates

Challenges showcases RebrAIn’s AI-powered innovation in Parkinson’s surgery

Mar 27, 2025

Challenges underscores the significance of RebrAIn's technology in enhancing the precision and efficiency of deep brain stimulation (DBS) surgeries. By leveraging machine learning algorithms trained on extensive clinical data, RebrAIn's software assists neurosurgeons...

From Patient to Practice: RebrAIn Wins the Resah Tender

Mar 19, 2025

The Strategic Importance of This Tender This success marks a major strategic turning point for RebrAIn, as the Resah procurement center plays a key role in the public healthcare sector in France. By enabling the member hospitals to choose the most effective...

The FUS Foundation highlights RebrAIn’s advances and validates its Board

Oct 12, 2024

Recently, the Focused Ultrasound Foundation highlighted RebrAIn's success in obtaining its second FDA 510(k) approval - which extends the capabilities of its OptimMRI software to include new machine learning models for lesioning treatment of Essential Tremor, thereby...

« Older Entries